Correlation Between Aclaris Therapeutics and Guardant Health

Can any of the company-specific risk be diversified away by investing in both Aclaris Therapeutics and Guardant Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aclaris Therapeutics and Guardant Health into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aclaris Therapeutics and Guardant Health, you can compare the effects of market volatilities on Aclaris Therapeutics and Guardant Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aclaris Therapeutics with a short position of Guardant Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aclaris Therapeutics and Guardant Health.

Diversification Opportunities for Aclaris Therapeutics and Guardant Health

-0.1

Correlation Coefficient

Aclaris Therapeutics  Guardant Health

Good diversification

The 3 months correlation between Aclaris and Guardant is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Aclaris Therapeutics and Guardant Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Guardant Health and Aclaris Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aclaris Therapeutics are associated (or correlated) with Guardant Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Guardant Health has no effect on the direction of Aclaris Therapeutics i.e., Aclaris Therapeutics and Guardant Health go up and down completely randomly.

Pair Corralation between Aclaris Therapeutics and Guardant Health

Given the investment horizon of 90 days Aclaris Therapeutics is expected to generate 0.6 times more return on investment than Guardant Health. However, Aclaris Therapeutics is 1.67 times less risky than Guardant Health. It trades about 0.2 of its potential returns per unit of risk. Guardant Health is currently generating about 0.06 per unit of risk. If you would invest  123.00  in Aclaris Therapeutics on February 4, 2024 and sell it today you would earn a total of  13.00  from holding Aclaris Therapeutics or generate 10.57% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Aclaris Therapeutics  vs.  Guardant Health

Aclaris Therapeutics

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Aclaris Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Aclaris Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Guardant Health

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Guardant Health has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's technical indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.

Pair Trading with Aclaris Therapeutics and Guardant Health

The main advantage of trading using opposite Aclaris Therapeutics and Guardant Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aclaris Therapeutics position performs unexpectedly, Guardant Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Guardant Health will offset losses from the drop in Guardant Health's long position.

The idea behind Aclaris Therapeutics and Guardant Health pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.